Home > Financial Ratios > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for JENBURKT PHARMACEUTICALS
Please provide your vote to see the results

JENBURKT PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 5.966.836.735.383.82

What is the latest EV/Core EBITDA ratio of JENBURKT PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of JENBURKT PHARMACEUTICALS is 5.96 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar20245.96
Mar20236.83
Mar20226.73
Mar20215.38
Mar20203.82

How is EV/Core EBITDA of JENBURKT PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 5.96
-12.74
Mar2023 6.83
1.49
Mar2022 6.73
25.09
Mar2021 5.38
40.84
Mar2020 3.82 -

Other Financial Ratios of JENBURKT PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of JENBURKT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS ₹423.5 Cr -3.7% -17.2% 27.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,246.0 Cr 4.7% -5.4% 0.5% Stock Analytics
DIVIS LABORATORIES ₹147,119.0 Cr 0.5% -9.8% 55.5% Stock Analytics
CIPLA ₹116,805.0 Cr 2% -1.8% -1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹103,554.0 Cr 2.6% -6.1% 14% Stock Analytics
DR REDDYS LABORATORIES ₹93,192.0 Cr -0.9% -10% -11.3% Stock Analytics


JENBURKT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS

-3.7%

-17.2%

27.1%

SENSEX

1.5%

-5.1%

0.6%


You may also like the below Video Courses